Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Eline Giraud and Elise Smolders on QT interval prolongation potential of anticancer

Eline Giraud and Elise Smolders on QT interval prolongation potential of anticancer

FromThe Lancet Oncology in conversation with


Eline Giraud and Elise Smolders on QT interval prolongation potential of anticancer

FromThe Lancet Oncology in conversation with

ratings:
Length:
12 minutes
Released:
Aug 30, 2022
Format:
Podcast episode

Description

Eline Giraud and Elise Smolders from the (Radboud University Medical Center, Nijmegen, Netherlands) discuss their Review on QT interval prolongation potential of anticancer and supportive drugs.Read the full Review:The QT interval prolongation potential of anticancer and supportive drugs: a comprehensive overviewContinue this conversation on social!Follow us today at...https://twitter.com/thelancet & https://Twitter.com/TheLancetOncolhttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv
Released:
Aug 30, 2022
Format:
Podcast episode

Titles in the series (100)

Editors of The Lancet Oncology and the journal’s authors explore their research and its impact on people’s health, health care, and health policy in this regular podcast.